Press Release – 15.05.2017 In July 2016, Episurf Medical participated in a pre-submission meeting with the FDA in Washington. Following this meeting, Episurf Medical submitted a 513(g) Request for Information for obtaining FDA’s views about the classification and the regulatory requirements that may be applicable to the Episealer device. Episurf Medical […]